Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent
1990-07-31
1992-03-17
Moskowitz, Margaret
Drug, bio-affecting and body treating compositions
Lymphokine
Interferon
530351, 530395, 435 6951, A61K 3766, C07K 1526
Patent
active
050967053
ABSTRACT:
Disclosed is a complete description of the preparation of novel, recombinant human immune interferon and des-CYS-TYR-CYS recombinant human immune interferon via recombinant DNA techniques utilizing any of an assortment of expression vectors and host cultures. The human immune (gamma) interferon (IFN-.gamma.), is isolated and characterized in terms of DNA and amino acid sequences, physical attributes and biological activity.
REFERENCES:
patent: 4285929 (1981-08-01), Sugimoto et al.
patent: 4382027 (1983-05-01), Braude
Yip et al., Proc. Natl. Acad. Sci., vol. 78, pp. 1601-1605, 1981.
Nathan et al., Nature, vol. 292, pp. 842-844, 1981.
O'Malley, Methods In Enzmology, vol. 78, pp. 540-545, 1981.
Hsieh et al., J. Biol. Chem., vol. 258, pp. 2548-2554, 1983.
Yamashita et al., Archives of Biochemistry, vol. 225, pp. 993-996, 1983.
Nakamura et al., Virology, vol.95, pp. 8-23, 1979.
Goeddel David V.
Gray Patrick W.
Baker R. Keith
Dreger Walter H.
Genentech Inc.
Moskowitz Margaret
LandOfFree
Human immune interferon does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human immune interferon, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human immune interferon will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1474604